日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations

基于分子谱分析确定个体化癌症治疗的证据调查(I-PREDICT)N-of-1精准肿瘤学研究:分子谱分析匹配个体化给药的个性化药物组合

Sicklick, Jason K; Nishizaki, Daisuke; Miyashita, Hirotaka; Okamura, Ryosuke; Hahn, Michael E; Nikanjam, Mina; Fanta, Paul T; Piccioni, David E; Patel, Hitendra; Eskander, Ramez N; McKay, Rana R; Ross, Jeffrey S; Lee, J Jack; Lippman, Scott M; Kato, Shumei; Kurzrock, Razelle

A Systematic Review with a Demonstrative Case of KIT and DOG-1 Expressing Gastrointestinal Stromal Tumors Harboring ETV6-NTRK3 Fusions.

系统性综述及KIT和DOG-1表达的胃肠道间质瘤携带ETV6-NTRK3融合的病例演示

Ranjbarian Tannaz, Antkowiak Mark, Mallory Robert J, Doherty Terence M, Hosseini Mojgan, Mesirov Jill P, Fanta Paul T, Sicklick Jason K

Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection

利用双重匹配生物标志物进行患者选择的基因靶向和免疫靶向联合疗法

Nishizaki, Daisuke; Kurzrock, Razelle; Adashek, Jacob J; Kim, Ki Hwan; Lim, Hyo Jeong; Nikanjam, Mina; Eskander, Ramez N; Fanta, Paul T; Okamura, Ryosuke; Lee, Suzanna; Sicklick, Jason K; Lippman, Scott M; Kato, Shumei

Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal Tumors

针对晚期胃肠道间质瘤的个性化N-of-1联合疗法

Noh, Sangkyu; Sharma, Ashwyn K; Fanta, Paul T; Kato, Shumei; Kurzrock, Razelle; Sicklick, Jason K

Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis

晚期胰腺癌的个性化匹配靶向治疗:一项初步队列分析

Shaya, Justin; Kato, Shumei; Adashek, Jacob J; Patel, Hitendra; Fanta, Paul T; Botta, Gregory P; Sicklick, Jason K; Kurzrock, Razelle

Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience

晚期结直肠癌的精准医疗治疗:加州大学圣地亚哥分校分子肿瘤委员会的经验

Louie, Bryan H; Kato, Shumei; Kim, Ki Hwan; Lim, Hyo Jeong; Lee, Suzanna; Okamura, Ryosuke; Fanta, Paul T; Kurzrock, Razelle

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

在 I-PREDICT 治疗初治研究中,晚期恶性肿瘤的分子谱分析指导一线 N-of-1 治疗方案的选择。

Sicklick, Jason K; Kato, Shumei; Okamura, Ryosuke; Patel, Hitendra; Nikanjam, Mina; Fanta, Paul T; Hahn, Michael E; De, Pradip; Williams, Casey; Guido, Jessica; Solomon, Benjamin M; McKay, Rana R; Krie, Amy; Boles, Sarah G; Ross, Jeffrey S; Lee, J Jack; Leyland-Jones, Brian; Lippman, Scott M; Kurzrock, Razelle

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

来自分子肿瘤委员会的真实世界数据显示,采用精准的N-of-One策略可改善治疗效果。

Kato, Shumei; Kim, Ki Hwan; Lim, Hyo Jeong; Boichard, Amelie; Nikanjam, Mina; Weihe, Elizabeth; Kuo, Dennis J; Eskander, Ramez N; Goodman, Aaron; Galanina, Natalie; Fanta, Paul T; Schwab, Richard B; Shatsky, Rebecca; Plaxe, Steven C; Sharabi, Andrew; Stites, Edward; Adashek, Jacob J; Okamura, Ryosuke; Lee, Suzanna; Lippman, Scott M; Sicklick, Jason K; Kurzrock, Razelle

Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies

RAS 改变在多种恶性肿瘤中的预后意义及靶向治疗的影响

Kato, Shumei; Okamura, Ryosuke; Sicklick, Jason K; Daniels, Gregory A; Hong, David S; Goodman, Aaron; Weihe, Elizabeth; Lee, Suzanna; Khalid, Noor; Collier, Rachel; Mareboina, Manvita; Riviere, Paul; Whitchurch, Theresa J; Fanta, Paul T; Lippman, Scott M; Kurzrock, Razelle

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

癌症患者的分子谱分析能够实现个性化联合治疗:I-PREDICT 研究

Sicklick, Jason K; Kato, Shumei; Okamura, Ryosuke; Schwaederle, Maria; Hahn, Michael E; Williams, Casey B; De, Pradip; Krie, Amy; Piccioni, David E; Miller, Vincent A; Ross, Jeffrey S; Benson, Adam; Webster, Jennifer; Stephens, Philip J; Lee, J Jack; Fanta, Paul T; Lippman, Scott M; Leyland-Jones, Brian; Kurzrock, Razelle